March 19, 2023
1 min learn
Miguel-Angel Perales, MD, has been named president of American Society for Transplantation and Mobile Remedy for 2023-2024.
Perales — chief of the grownup bone marrow transplantation service at Memorial Sloan Kettering Most cancers Heart and professor of medication at Weill Cornell Medical School — will direct the society’s new strategic plan and supply extra science focus to assist advance therapy choices, in line with a press launch.
Perales has been a member of ASTCT since 2001. He has served on the society’s board of administrators since 2017.
“I’ve loved serving on the ASTCT board of administrators, and I’m honored to function president this 12 months,” Perales mentioned within the launch. “In my observe, my sufferers have a wide range of hematologic malignancies and are in want of an allogeneic transplant or mobile remedy. The objective of my observe, analysis, and now as president of ASTCT is to additional advocate for our sufferers and help our area by advancing the science and additional offering instructional alternatives for our members.”
Perales’ analysis focus consists of enhancing outcomes for sufferers present process stem cell transplantation, together with decreasing threat for problems, relapse and graft-versus-host illness. He is also conducting translational analysis to review new methods to enhance immune system restoration after transplant.
Perales is chair of Alliance for Scientific Trials in Oncology’s transplantation and cell-based therapies committee. He is also a member of the board of administrators of Be The Match (Nationwide Marrow Donor Program).
He has held management positions with Heart for Worldwide Blood and Marrow Transplant Analysis, in addition to Blood and Marrow Transplantation Scientific Trials Community.
